GENSIGHT BIOLOGICS
EURONEXT PARIS
FR Flag
SIGHT

SIGHT
GENSIGHT BIOLOGICS
FR Flag
EURONEXT PARIS
 
Next Earning
Market Cap
EPS
Div Yield
P/E
Next Earning
Market Cap
EPS
Div Yield
P/E

SIGHT Stock Chart

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Healthcare
Industry: Biotechnology & Medical Research
Employees: 37
Gensight Biologics SA is a France-based company, which specializes in the clinical-stage biotechnology and development of novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The Company, through I ts integrated development platform, combines a gene therapy-based approach with core technology platforms of mitochondrial targeting sequence and optogenetics. It focuses on development of therapies for severe retinal diseases with the goal of preserving or restoring vision in patients with sight-threatening ophthalmic diseases. The Company provides two development programs with products, such as GS010 which aims at treating rare mitochondrial genetic disease, and GS030 which technology makes cells responsive to light. The products are designed to be administered in a single treatment to each eye by intravitreal or subretinal injection.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Get Help Feature Request Blog & News FAQ Wiki Twitter
Profile Profile Settings Account and Billing Get Help Ideas Published Followers Following Private Messages Chat Sign Out